Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples